Boutique CAR T-Cell Advisory
Regulatory | Business & Clinical Development | Manufacturing & Intellectual Property
Cell and Gene Therapy is the Future of Medicine. Let’s Explore Together.
Our car t-cell focus and expertise
Our expert consultations have helped such public and private clients as:
CAR T-Cell Regulatory Advisory and Consultancy
This service involves advising clients on the regulatory requirements and guidelines for CAR-T cell therapy development and commercialization, including FDA, EMA, and other international regulatory agency best practices.
CAR T-cell Manufacturing and Supply Chain Advisory
This service involves advising clients on the development and optimization of manufacturing processes and supply chain strategies for CAR-T cell therapy production. Optimizing existing processes, costs, and regulatory strategies.
WHO WE ARE?
CAR T-cell Advisory by Medrego is a boutique consultancy addressing “Everything CAR T-cell.”
We empower Government bodies and private solution therapy providers to overcome the multitude of challenges presented by the complex regulatory environment, manage potential risks effectively, ensure the unwavering quality and safety of their products, and ultimately, achieve successful market launches.
The compound annual growth rate for CAR-T therapies in 2024 is predicted to be around 19%.
Several gene therapies are currently in their pivotal stages, and we expect regulatory decisions for them to be reached in the coming year. If, as predicted, these therapies are approved, non-oncology applications will gain relevance, reaching a much larger population.
Is Your Governmental Body Ready For the Future of Medicine?
Latest CAR T-CELL Advisory news & Blog Posts
Advanced Therapy Medicinal Product (ATMP) Regulations in Europe – 2024 Report
The field of medicine stands on the brink of a revolution. Advances in treatments, such as genetically modified chimeric antigen …
7 Cell and Gene Therapy Solutions You Need To Be Watching Closely
In the ever-evolving landscape of healthcare, cell and gene therapy solutions stand at the forefront of groundbreaking innovations. As we …
Navigating the Future of ATMP: Overcoming Gene and Stem Cell Development Hurdles in 2024
The realm of biotechnology is on the brink of revolutionizing medical treatments through Advanced Therapy Medicinal Products (ATMP), particularly in …
Do not miss out on the industry growing 35% a year. Reaching USD 85B by 2032.*
*T-cell Therapy Market. Precedence Research